Andreas Neisius - Concepedia

Author

Andreas Neisius

Johannes Gutenberg University Mainz ORCID

Also Known As

A. Neisius, Andreas Neisius, Anja Lorch, Duvdevani Mordechai, Judith Lorenz, Mitran, Sorin, Neisius, Andreas

180

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

Johannes Gutenberg University Mainz Duke Medical Center University Medical Center of the Johannes Gutenberg University Mainz Krankenhaus der Barmherzigen Brüder Trier Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie

About

Andreas Neisius is an author at Johannes Gutenberg University Mainz specializing in urology, medicine, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	18	2.2K
2	Engineering	2	2	52
3	Nephrology	2	2	86
4	Health Sciences	1	1	32
5	Public Health	1	1	14

Andreas Neisius

Publications

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, The Lancet Oncology First-line TherapyUrologyChemotherapy Versus ChemotherapyGenitourinary CancerMedicine	2021	627
EAU Guidelines on Assessment and Nonsurgical Management of Urinary Incontinence Malcolm G Lucas, Ruud Bosch, Fiona C. Burkhard, European Urology UrologyVoiding DysfunctionPatient SafetyPelvic ProlapseEau Guidelines	2012	418
EAU Guidelines on Urinary Incontinence Joachim W. Thüroff, Paul Abrams, Karl‐Erik Andersson, European Urology UrologyVoiding DysfunctionPelvic ProlapseUrinary IncontinencePatient Safety	2010	380
EAU Guidelines on Surgical Treatment of Urinary Incontinence Malcolm G Lucas, Ruud Bosch, Fiona C. Burkhard, European Urology UrologyVoiding DysfunctionEau GuidelinesUrogynecologySurgery	2012	290
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Thomas Powles, Piotr Tomczak, Se Hoon Park, The Lancet Oncology	2022	262
European Association of Urology Guidelines on the Diagnosis and Treatment of Urolithiasis Andreas Skolarikos, Robert Geraghty, Bhaskar Somani, European Urology Urological ResearchUrologyRenal PathologyUrogynecologySurgery	2025	75
Clinical outcomes and costs of reusable and single-use flexible ureterorenoscopes: a prospective cohort study René Mager, M. Kurosch, Thomas Höfner, Urolithiasis Urological ResearchUrologySingle-use Flexible UreterorenoscopesOutcomes ResearchClinical Outcomes	2018	71
Effect of Supine vs Prone Position on Outcomes of Percutaneous Nephrolithotomy in Staghorn Calculi: Results From the Clinical Research Office of the Endourology Society Study Gastón M. Astroza, Michael E. Lipkin, Andreas Neisius, Urology Staghorn CalculiUrologyClinical Research OfficePatient SafetyPerioperative Safety	2013	66
Survival outcomes in patients with large (≥7cm) clear cell renal cell carcinomas treated with nephron-sparing surgery versus radical nephrectomy: Results of a multicenter cohort with long-term follow-up Martin Janssen, Johannes Linxweiler, S. Terwey, PLoS ONE	2018	53
Radiation Exposure in the Follow-Up of Patients with Urolithiasis Comparing Digital Tomosynthesis, Non-Contrast CT, Standard KUB, and IVU Gastón M. Astroza, Andreas Neisius, Agnes J. Wang, Journal of Endourology	2013	39

Page 1